Investigation and control of a Plasmodium falciparum malaria outbreak in Shan Special Region II of Myanmar along the China-Myanmar Border from June to December 2014

Infectious Diseases of Poverty

Volumn 5, Issue 1, 2016, Pages

  Liu, Hui ^a   Xu, Jian Wei ^a   Yang, Heng Lin ^a   Li, Mei ^b   Sun, Cheng De ^c   Yin, Yi Jie ^a   Zheng, Zhi Liang ^d   Zhang, Guang Yun ^d   Yu, Ai Shui ^e   Yang, Yong Hui ^e   Li, Chun Hui ^e   Ai, Shui ^f  

^a Yunnan Institute of Parasitic Diseases Yunnan Provincial Centre of Malaria Research Yunnan Provincial Key Laboratory of Vector borne Diseases Control and Research   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Wa State Department of Health   (Myanmar)

^d Wa State Office of Health Poverty Action   (Myanmar)

^e Menglian Center for Disease Control and Prevention   (China)

^f Wa State Center for Disease Control and Prevention   (Myanmar)

Author keywords

Chinese Myanmar border; Control; Investigation; Malaria outbreak; Plasmodium falciparum

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; DNA; INSECTICIDE; PARASITE ANTIGEN; ANTIMALARIAL AGENT;

ADOLESCENT; ANOPHELES MACULATES; ANOPHELES MINIMUS; ANOPHELES SINENSIS; ARTICLE; ASEXUAL PARASITE CLEARANCE TIME; BED NET; BEHAVIOR CHANGE; CHILD; CHROMOSOME 13; CROSS-SECTIONAL STUDY; DISEASE CONTROL; FEMALE; FEVER CLEARANCE TIME; GENOTYPE; HUMAN; INCIDENCE; INDOOR RESIDUAL SPRAYING; INTERVIEW; MALARIA; MALARIA FALCIPARUM; MALE; MICROSCOPY; MYANMAR; PARASITOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAPID TEST; RETROSPECTIVE STUDY; RISK FACTOR; ZOOLOGY; ADULT; AGED; ANIMAL; CHINA; CLASSIFICATION; EPIDEMIC; GENETICS; INFANT; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MIDDLE AGED; MOSQUITO; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; TRAVEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHINA; CULICIDAE; DISEASE OUTBREAKS; FEMALE; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; MYANMAR; PLASMODIUM FALCIPARUM; TRAVEL; YOUNG ADULT;

EID: 84992307761     PISSN: None     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/s40249-016-0127-8     Document Type: Article

References (31)

1. WHO. World malaria report 2014. Geneva: World Health Organization; 2014. accessed Jun 27, 2015.
2. Feachem RG, Phillips AA, Hwang J, Cotter C, Wielgosz B, et al. Shrinking the malaria map: progress and prospects. Lancet. 2010;376:1566-78.
3. Tatem AJ, Smith DL, Gething PW, Kabaria CW, Snow RW, et al. Ranking of elimination feasibility between malaria-endemic countries. Lancet. 2010. doi: 10.1016/S0140-6736(10)61301-3.
4. Gosling RD, Whittaker M, Gueye CS, Fullman N, Baquilod M, et al. Malaria elimination gaining ground in the Asia Pacific. Malar J. 2012;11:346.
5. Ministry of Health, People's Republic of China. Malaria elimination action plan 2010-2020 (in Chinese). Beijing: The Ministry; 2010. accessed Jun 25, 2011.
6. Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, et al. Malaria in the Greater Mekong Subregion: heterogeneity and complexity. Acta Tropica. 2012;121:227-39.
7. Delacollette C, Souza C, Christophel E, Thimasarn K, Abdur R, Bell D, et al. Malaria trends and challenges in the Greater Mekong Subregion. Southeast Asian J Trop Med Public Health. 2009;40:674-91.
8. WHO. Malaria in the Greater Mekong Subregion: regional and country profiles. Bangkok: The Representative Office for World Health Organization to Thailand; 2008. Accessed Oct 26, 2014
9. WHO. Emergency response to artemisinin resistance in the Greater Mekong subregion: regional framework for action 2013-2015. Geneva: World Health Organization; 2013. accessed Jul 26, 2015.
10. Greenwood B. Treatment of malaria-a continuing challenge. N Engl J Med. 2014;371:474-5.
11. Dondorp A, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-67.
12. Phyo AP, Nkhoma S, Stepniewska K, Ashley E, Nair S, Gready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960-6.
13. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
14. Liu P, Guo Y, Qian X, Tang S, Li Z, Chen L. China's distinctive engagement in global health. Lancet. 2014;384:793-804.
15. Xia ZG, Feng J, Zhou SS. Malaria situation in the People's Republic of China in 2012 (in Chinese). Chin J Parasitol Parasit Dis. 2013, 31413-418.
16. Wang RB, Zhang J, Zhang QF. Malaria baseline survey in four special regions of northern Myanmar near China: a cross-sectional study. Malaria Journal. 2014;13:302.
17. China Office for the tenth Global Fund to fight Malaria: Impact Evaluation of Malaria Control across Chinese-Myanmar Border (in Chinese). Dissemination workshop of China's tenth Global Fund to fight Malaria. Puer, Mar 31, 2014. The Office; 2014.
18. Liu H, Yang HL, Tang LH, Li XL, Huang F, Wang JZ, et al. Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013. Malar J. 2014;13:364.
19. Liu H, Yang HL, Tang LH, Li XL, Huang F, Wang JZ, et al. In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China during 2007-2013. Malar J. 2015;14:47.
20. Zhou HN, Zhang ZX, Li CF, Wu C, Wang PY, Chris C, et al. The role of the malaria vectors in the upper valley of Mekong River in Yunnan. Chin J Parasit Dis Con. 2005;18:407-11.
21. WHO. Method for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009. p. 82. accessed Sep 27, 2011.
22. WHO. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization; 2003. WHO/RBM/HTM/2003.50) (accessed Oct 20, 2014.
23. WHO. Recommended Genotyping Procedures (RGPs) to identify parasite populations. Amsterdam: Medicines for malaria Venture and World Health Organization; 2007. accessed Sep 27, 2011.
24. WHO. Methods and techniques for clinical trials on antimalarial efficacy: genotyping to identify parasite populations. Geneva: World Health Organization; 2008. accessed Sep 27, 2011.
25. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50-5.
26. Tun K, Imwong M, Lwin K, Win A, Hlaing T, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular Marker. Lancet Infect Dis. 2015;15:415-21.
27. Berger F, Flamand C, Musset L, Djossou F, Rosine J, Sanquer MA, et al. Investigation of a sudden malaria outbreak in the isolated Amazonian village of Saul, French Guiana, January-April 2009. Am J Trop Med Hyg. 2012;86:591-7.
28. Xu JW, Liu H, Zhang Y, Guo XR, Wang JZ. Risk factors for border malaria in a malaria elimination setting: a retrospective case-control study in Yunnan, China. Am J Trop Med Hyg. 2015;92:546-51.
29. Gillet P, Dijk D, Bottieau E, Cnops L, Esbroeck MV, Jacobs J. Test characteristics of the SD FK80 Plasmodium falciparum/Plasmodium vivax malaria rapid diagnostic test in a non-endemic setting. Malar J. 2009;8:262.
30. Wu L, Hoogen L, Slater H, Walker P, Ghani A, Drakeley C, et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. Nature. 2015;528:S86-93.
31. MOH, People's Republic of China. Malaria control manual (in Chinese). Beijing: People's Press of Health; 2007. p. 133-43. accessed Sep 22, 2008.